毛片免费毛片一级jjj毛片,日本在线亚州精品视频在线,国产精品国偷自产在线,久久精品色,日韩精品免费电影,欧美综合国产精品日韩一,国产六区

首頁 /藥靶模型 /免疫治療 /Combination /PDL1 aAPC Cell

PDL1 aAPC Cell

CBP74164

詢 價
索取Protocol
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
I. Background
The binding of Programmed Cell Death Protein 1 (PD-1), a receptor expressed on activated T-cells, to its ligands, PD-L1 and PD-L2, negatively regulates immune responses. The PD-1 ligands are found on most cancers, and PD-1:PD-L1/2 interaction inhibits T cell activity and allows cancer cells to escape immune surveillance. The PD-1:PD-L1/2 pathway is also involved in regulating autoimmune responses, making these proteins promising therapeutic targets for a number of cancers, as well as multiple sclerosis, arthritis, lupus, and type I diabetes.
 
II. Introduction
Expressed gene: PDL1
Stability: 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)
Freeze Medium: 90% FBS+10% DMSO
Culture Medium: RPMI-1640+10%FBS+1ug/ml puromycin+200ug/ml hygromycin
Mycoplasma Testing: Negative
Storage: Liquid nitrogen
Application(s): Functional(Report Gene) Assay
 
III. Representative Data

Figure 1. Dose Response of Blocking Antibodies in PD-1/OX40 Dual Effector Reporter Cells (C22) With PD-L1 aAPC Cells.

 

Figure 2.Dose Response of Blocking Antibodies in PD-1/41BB Dual Effector Reporter Cells (C64) With PD-L1 aAPC Cells.

客服

微信

掃一掃,添加二維碼

電話

留言

藥靶模型聯(lián)系方式: 華東銷售經(jīng)理(上海):18240630236 華東銷售經(jīng)理(上海、江蘇、安徽):15715191010 華中&華西銷售經(jīng)理:18071545918 華中&西南銷售經(jīng)理:13871580511 華北銷售經(jīng)理:18628311252 全國銷售經(jīng)理:13816461235
診斷標準品聯(lián)系方式: 華東銷售經(jīng)理:15000320447 華北銷售經(jīng)理:18628311252 華中&華西銷售經(jīng)理:18071545918 華中&西南銷售經(jīng)理:13871580511 全國銷售經(jīng)理:13816461235

掃二維碼

立即提交
临安市| 无锡市| 嘉黎县| 耿马| 三门县| 云梦县| 娄烦县| 金湖县| 大化| 孟村| 鱼台县| 宁波市| 金乡县| 策勒县| 淮南市| 新巴尔虎左旗| 集贤县| 安平县| 开阳县| 黎川县| 右玉县| 盐亭县| 砀山县| 城市| 扶余县| 林口县| 阜阳市| 鹤岗市| 门头沟区| 鲁山县| 漳浦县| 安义县| 上高县| 普兰店市| 沙湾县| 无为县| 怀化市| 仪征市| 宝清县| 林州市| 文成县|